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Abstract  
Introduction: Cervical cancer prevalence in Rwanda has not been well-described. Visual inspection with acetic acid or Lugol solution has been 
shown to be effective for cervical cancer screening in low resource settings. The aim of the study is to understand the prevalence and risk factors 
for cervical cancer and pre- cancerous lesions among Rwandan women between 30 and 50 old undergoing screening. Methods: This cross-
sectional analytical study was done in 3 districts of Rwanda from October 2010 to June 2013. Women aged 30 to 50 years screened for cervical 
cancer by trained doctors, nurses and midwives. Prevalence of pre-cancerous and cancerous cervical lesions was determined. Bivariate and 
multivariate logistic regressions were used to assess risk factors associated with cervical cancer. Results: The prevalence of pre-cancer and 
invasive cervical cancer was 5.9% (95% CI 4.5, 7.5) and 1.7% (95% CI 0.9, 2.5), respectively. Risk factors associated with cervical cancer in 
multivariate analysis included initiation of sexual activity at less than 20 years (OR=1.75; 95% CI=(1.01, 3.03); being unmarried (single, divorced 
and widowed) (OR=3.29; 95% CI=( 1.26, 8.60)); Older age of participants (OR= 0.52; 95% CI= (0.28, 0.97)), older age at the first pregnancy 
(OR=2.10; 95% CI=(1.20, 3.67) and higher number of children born (OR=0.42; 95%CI =(0.23, 0.76)) were protective. Conclusion: Cervical 
cancer continues to be a public health problem in Rwanda, but screening using VIA is practical and feasible even in rural settings.  
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Cervical cancer is the fourth most common cancer in women 
worldwide and the second most common female cancer in women 
aged 15-44 years old worldwide [1]. In 2012 there were an 
estimated 528,000 new cases of cervical cancer and 266,000 deaths 
from cervical cancer, with 70% of those deaths occurring in 
developing countries [2]. In Sub-Saharan Africa, cervical cancer 
accounts for 22.5% of all cancer cases in women, and the majority 
of women who develop cervical cancer live in rural areas [3]. 
Eastern Africa is one of the most heavily affected areas with an 
incidence of more than 30 cases per 100,000 women per year [4]. 
Rwanda has a population of 11 million with 2.72 million women 
aged 15 years and older who are at risk of developing cervical 
cancer [5]. Current estimates indicate that every year nearly one 
thousand women are diagnosed with cervical cancer and almost 700 
die from the disease [6]. Cervical cancer ranks as the most frequent 
cancer among women in Rwanda, and the most frequent cancer 
among women between 15 and 44 years of age [7]. The estimated 
incidence of cervical cancer in Rwanda is 49 cases per 100,000 
women per year, much higher than the estimated rates in Eastern 
Africa and worldwide, 34.5 and 16 new cases per 100,000 women, 
respectively [8]. Several key risk factors for cervical cancer are 
common in sub-Saharan countries, including prolonged HPV 
infections and HIV/AIDS which is endemic in this region (UNAIDS 
report 2012). Other risk factors include debut of sexual activity 
before age of 20 years old, multiple sexual partners, tobacco 
smoking, oral contraceptive pill use for more than 5 years, history of 
cervical cancer in the family, high parity (more than 3 children 
born), and immune-depression due to malnutrition or other systemic 
diseases [9].  
  
In low resource countries, cytology-based screening programs 
and/or DNA typing of HPV are usually beyond the capacity of many 
health services. Visual inspection of the cervix using acetic acid 
(VIA) or Lugol's iodine (VILI) to highlight precancerous lesions 
allows identification of pre-cancerous lesions in the clinic instead of 
the laboratory. With adequate training, any health care provider, 
including doctors, nurses, or nurse-midwives, can effectively 
perform the procedure [10]. VIA may perform as well as or better 
than cervical cytology in identifying pre-cancerous lesions [10, 11]. 
Different studies have demonstrated that using VIA, trained 
physicians and other providers correctly identified between 45% and 
79% of women at high risk of developing cervical cancer [10]. In 
comparison, the sensitivity of cytology has been shown to be 
between 47 and 62% [12]. Paired with cryotherapy, VIA has 
successfully been implemented as a relatively simple, acceptable, 
and cost effective method of treating cervical lesions and preventing 
development of cervical cancer in resource-limited settings [13-17]. 
In 2010, the Government of Rwanda initiated training for health 
providers in VIA and cryotherapy, with the goal of launching a 
national cervical cancer screening program for all women between 
30 and 50 years old. In combination with trainings, initial screenings 
were conducted in several districts to collect baseline information. 
Having accurate data on cervical cancer prevalence will help guide 
control and prevention of cervical cancer in Rwanda as it can help 
determine the effectiveness of screening and treatment programs 
and guide resource allocation for treatment. This study was 
conducted to further understand the prevalence and risk factors for 
cervical cancer and pre- cancerous lesions among Rwandan women 






Type of study: this is a descriptive cross-sectional and analytical 
study. Data collection was done from subjects at the time of cancer 
screening through use of a standardized questionnaire.  
  
Study population: the study population consisted of women aged 30 
to 50 years old who were screened for cervical cancer in 3 districts 
in Rwanda from October 2010 to June 2013. Sensitization on 
cervical cancer screening was done by radio advertisements and 
with the help of community health workers before and during the 
screening period. Participants were recruited from the population of 
the 3 districts without regard to HIV status. Women were excluded 
from the study if they were more than 20 weeks pregnant; less than 
12 weeks post-partum; had a previous history of treatment of 
cancerous lesions; had a known allergy to acetic acid; or if they had 
undergone total hysterectomy. By convenience this study was 
conducted in 3 districts offering screening during the early stages of 
the national campaign: Musanze District (with 2 sites: Ruhengeri 
district hospital and Kinigi health center) from North Province; 
Rwamagana (two sites: Rwamagana District hospital and Avega 
health center); and Kayonza district (five sites: Rwinkwavu and 
Gahini district hospitals, Mukarange, Nyamirama and Kabarondo 
health centers) from Eastern Province.  
  
Data collection procedures: a chart abstraction instrument was 
elaborated for collecting data from participant files. Information in 
files was collected by trained providers during systematic screening, 
and data were extracted retrospectively from those files stored in 
the three sites by providers from the respective sites.  
  
Screening procedures: screening was done by medical doctors, 
nurses, and midwives with 3 years of experience in maternity 
service who had been trained for 2 weeks in theory and practice in 
cervical cancer screening. The following procedures were followed 
for screening: (1) Speculum examination: If a lesion suspicious for 
invasive cervical cancer was noted, colposcopy was performed and 
women were referred to referral hospitals (Kigali and Butare 
University Teaching hospitals and king Faycal Hospital) for biopsy. If 
no lesions concerning for invasive cervical cancer were seen, VIA 
was performed to detect pre-cancer lesions (acido-white lesions); 
(2) For VIA positive women with minor lesions, cryotherapy was 
performed to remove pre-cancer lesions. For VIA positive women 
with larger lesions, the Loop Excision Electrical Procedure (LEEP) 
was performed by trained medical doctors; (3) Women with pre-
cancer lesions treated with cryotherapy were recommended to 
follow up after 3 months for clinical evaluation and one year later 
for re-screening.  
  
Variables: two dependent variables of interest were chosen: 
Invasive cervical cancer was defined as a binary variable with an 
outcome of diagnosis of invasive cervical cancer. Invasive cervical 
cancer lesions were diagnosed clinically if lesions suggestive of 
invasive cancer were found on the cervix. All cases were confirmed 
by colposcopy and biopsy; cervical pre-cancer was defined as a 
binary variable. Cervical pre-cancer lesions were diagnosed clinically 
after application of acetic acid or vinegar at 5%. Independent 
variables included: socio-demographic variables: these included age, 
sex, educational level, provenance, marital status and socio-
economic status. Socioeconomic status was defined in accordance 
with the Demographic and Health Survey 2010 [5] considering 
housing conditions with having access to electricity and improved 
water and also considering ownership of goods (radio, mobile 
phone, bicycle, car, agriculture land etc.). HIV status was obtained 
by self-report; clinical and behavioral variables: age of first 
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intercourse, number of sexual partners, sexual transmitted 
infections (STIs) were assessed by clinical examinations. For STIs, a 
syndromic approach was used in diagnosis and treatment, Number 
of pregnancies and number of children delivered, age of the first 
and last pregnancy, use of oral contraceptive pills as family 
planning, HIV status, smoking and alcohol use were considered as 
independent variables  
  
Statistical analysis: double data entry was done with Epi Data 3.1 by 
trained staff. After data cleaning, data were exported into SPSS 16.0 
for analysis. For descriptive and data summary purposes, univariate 
techniques were applied to single sets of data. Graphical and tabular 
techniques included frequencies and bar graphs. Summary statistics 
such as mean and standard deviation were calculated for continuous 
variables. Bivariate methods were used to show the relationship 
between variables; contingency tables were used to describe 
relationship between categorical variables. Tabular methods of 
describing the relationship between two nominal variables by finding 
proportions were also employed. Multivariate analysis was used to 
determine the socio-demographic, behavioral and clinical factors 
associated with cervical cancer and pre-cancer lesions. Binary and 
multinomial logistic regressions were used to show the association 
of any cervical cancerous lesion with different factors In order to 
facilitate regressions, most variables were made into binary 
variables (age group, marital status, education level, social 
economic status, number of pregnancies, number of children born, 
age of the first pregnancy and number of sexual partners) to 
facilitate analysis of the association of cervical cancer and pre-
cancer with different factors. After bivariate analysis, a series of 
multivariate regressions were conducted: all variables with P-value 
below 0.10 in bivariate analyses were included in multivariate 
regression, after those variables with p-value <0.10 with cofounding 
variables were also included in another series of multivariate 
regression to find out final variables associated with any cervical 
cancerous lesion.  
  
Ethical considerations: the Rwanda School of Public Health Internal 
Review Board approved the study, and site authorizations were 





Study population  
  
Socio-demographic characteristics of our study population are 
shown in Table 1. The mean age of women was 37.0 years with 
the majority of participants (75%) between 30 and 40 years old. 
The majority were married (84%), and 81.9% had received no 
education or primary school only. The majority of women (66.4%) 
were from the Eastern province. Gynecological-obstetrical and other 
clinical characteristics among women screened for cervical cancer 
are displayed in Table 2. Most women reported 4 or more 
pregnancies (65%). The majority of participants (80%) who were 
taking oral contraceptives used them for less than 5 years. Half of 
the respondents had their sexual debut when they were over 20 
years old, and two-thirds reported only one lifetime sexual partner. 
Almost 10% of the population reported a diagnosis of HIV, while 
nearly 80% reported themselves to be HIV negative; however, 12% 
did not know their HIV status.  
  
Cervical pre-cancer lesions (VIA positive) and cancer prevalence  
  
Table 3 shows the prevalence of pre-cancer (VIA positive) and 
cancer lesions by risk factor. The overall prevalence of cervical pre-
cancer lesions was 5.9%, while the overall prevalence of cervical 
cancer was 1.7% (17 cases out of 1002 women screened). Pre-
cancer lesions (VIA positive) were most prevalent in the 30-35 year 
old group, in those who were married, in the group with no 
education, in those with low level socio-economic status, in 
participants with one pregnancy, in participants with one child born, 
in participants who had the first pregnancy before 20 years old, in 
participants who had first sexual intercourse before age 20, in those 
who self-reported HIV positivity, in participants who had had more 
than 5 sexual partners, and in participants who smoked.  
  
Risk factors for cervical cancer lesions  
  
Table 4 shows the characteristics that were risk factors for invasive 
cervical cancer using bivariate and multivariable analysis. Using 
binary logistic regression to assess the relationship between cervical 
pre-cancer or invasive cancer and the independent variables 
collected, we found that being unmarried was the only risk factor 
associated with cervical cancer (P= .040 with OR=2.6 with 95%CI= 
(1.05-6.69)). After bivariate analysis, variables with P<.10 and other 
variables qualified as confounders for cervical cancer risk factors 
were included in multivariate logistic regression models to 
determine their association with invasive cervical cancer or pre-
cancerous lesions analyzed by association with cervical cancer 
lesions (invasive and pre-cancer lesions both) as dependent 
variables by series (two times) after elimination of variables with P> 
.05 (multivariate analysis). With multivariate regression, the risk of 
developing any cervical cancerous lesion decreased with increasing 
party (OR=0.42; 95%CI= 0.23-0.76). Being older than 40 
decreased risk (OR=0.52; 95%CI= 0.28-0.97). The risk increased if 
age of the first sexual intercourse was less than 20 years old 
(OR=1.75; 95% CI = (1.01-3.03)); it increased also in participants 
who live alone (single, divorced and widowed) (OR=3.29; 95%CI = 
(1.26-8.60)). The risk was increased with age of the first pregnancy 
less than 20 years old (OR=2.10; 95% CI = (1.20-3.67)). The total 





This study is the first large-scale analysis of population-based 
cervical screening results using VIA from women aged 30 to 50 
years old in Rwanda. The prevalence of cervical cancer and pre-
cancer lesions was 1.7% and 5.9%, respectively. Younger age, 
earlier age of the first pregnancy, early sexual debut, and higher 
number of children born were all risk factors for cervical cancer. 
Risk factors for cervical cancer in this study were similar to other 
studies in sub-Saharan Africa where cervical cancer screening using 
VIA was used.  
  
This study showed a prevalence of 1.7% for cervical cancer and 
5.9% for pre-cancer among our study population. These results are 
similar to those from other resource limited settings in sub-Saharan 
Africa; for example, in Nigeria the prevalence of pre-cancer lesions 
were between 4.8-14% [18]. Compared with a pooled analysis of 
data from Malawi, Madagascar, Nigeria, Uganda, Tanzania, and 
Zambia, the prevalence of invasive cancer in the Rwandan setting 
was similar, whereas the prevalence of pre-cancer in this study was 
lower. In those six countries, a total of 19,579 clients were screened 
with 10.1% having positive VIA results and 1.7% with probable 
cancer [14]. In a study done in northern Thailand, the VIA test-
positive rate was 13.3% in nearly 6,000 women, much higher than 
the prevalence of pre-cancer in our study [19]. The mean age of the 
women presenting for screening in this study was 37.0 years and 
most participants were between 30 and 35 years old (47.7%). 
These findings demonstrate higher participation in screening of 
younger women, similar to other studies in Africa like in Nigeria, 
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where the population screened was younger than the general 
population [18]. Older age of participants was also associated with 
lower risk for invasive and precancerous lesions in adjusted 
analyses. Because we considered both invasive cancer and pre-
cancer lesions together as our outcome of interest in multivariate 
analyses, the prevalence of pre-cancer lesions affected this 
association. Another study done in Rwandan women in Kigali that 
assessed HPV infection and cervical cytology in HIV positive and HIV 
negative women showed that HPV prevalence and carcinogenic HPV 
decreased with age [7]. Cervical cancer has long been associated 
with HIV infection, and in fact, it was added as and AIDS-defining 
illness to early AIDS case definitions by the CDC. In the present 
study, women with HIV had a higher frequency of cervical pre-
cancer lesions (8.2%), although the association was not statistically 
significant. As women with HIV have a higher frequency of HPV co-
infection, rates of pre-cancer and cancer are typically higher. 
Previous studies in sub-Saharan Africa have demonstrated a 
consistent association of cervical cancer and HIV (e.g. Senegal [20]; 
South Africa, Zimbabwe [21]; and also in other low-and middle 
income countries [22]. Given the low prevalence of cervical cancer 
in this study, we were not able to detect an association with HIV 
infection status.  
  
Similar to prior studies, in these Rwandan women the risk of cervical 
cancer increased with young age of the first sexual intercourse 
(OR=1.75; 95% CI = (1.01-3.02) and in women who live alone 
(single, divorced and widowed) (OR=3.29; 95% CI = (1.26-8.60)). 
Having sex at earlier age and having multiple partners increases the 
risk of infection with a high risk human papillomavirus (HPV) [23]. 
This association was also seen in a case-control study of cervical 
cancer risk factors in Indian women where maximum risk of cervical 
cancer was increased in women with a sexual debut at <12 years 
old (OR=3.5) and also increased in women who had extramarital 
sexual relationships (OR = 5.5) [24]. This association of cervical 
cancer with sexual behavior also was shown in a case- control study 
done in Manchester, England where the number of sexual partners 
was the only risk factor (OR for six or more = 3.89) [25]. We linked 
marital status and number of partners because it is known that 
living situation is correlated to having multiple sexual partners. VIA 
was used as the screening test for all study participants. American 
Cancer Society guidelines suggest cervical cancer screening from 21 
years old to 65 years old when using only Pap smear or visual 
inspection and from 30 years old to 65 years old when HPV DNA 
test is associated to these above mentioned tests [23]. Because VIA 
needs to be performed at regular frequency (every year for PLWH 
and every three years for HIV negative women), the Rwanda MOH 
has planned to include HPV DNA testing with VIA in the future; HPV 
DNA test was not yet available in Rwanda at the time of our study.  
  
This study had several limitations. As the study was a convenience 
sample of women presenting for care from 3 districts in Rwanda, 
the prevalence results may not be generalizable to the whole of 
Rwanda or to the East African female population, where HIV 
infection rates are quite varied. There is also a possibility of 
selection bias, as women who participated in the screening program 
may have been more likely to have current symptoms or be more 
likely to be HIV-infected since the reported prevalence of HIV in the 
study population was higher than the national prevalence for HIV 
(10% vs. 3%). The main purpose of this study was to serve as a 
baseline for further studies and to help in planning for cervical 
cancer screening in Rwanda; future studies using randomized 
sampling techniques may give a more complete estimation of the 
national prevalence. Additionally, this study relied on chart review to 
confirm clinical variables (e.g. HIV status) which may have led to 
misclassification based on incomplete or inaccurate documentation. 
Lastly, there were limited variables available for analysis in the 
medical records, limiting the number of risk factors and confounders 





Cervical cancer continues to be a public health problem in Rwanda, 
but screening using VIA is practical and feasible even in rural 
settings. These preliminary results from 3 districts should be 
expanded to develop a complete national picture for Rwanda. Risk 
factors for cervical cancer in this study (age of participants, age of 
the first pregnancy, sexual behavior, and number of children) were 
similar to those previously described. Implementation of cervical 
cancer screening in all eligible Rwandan women should be a 
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Table 1: socio-demographic characteristics of women screened 
for cervical cancer 
Characteristic n (%) 
Age (N=1002)   
30-35 years 478 (47.7) 
36-40 years 275 (27.4) 
41-45 years 135 (13.5) 
46-50 years 114 (11.4) 
Marital status (N=892)   
Single 16 (1.8) 
Married 748 (83.9) 
Divorced  66 (7.4) 
Widowed 62 (7.0) 
Education completed (N=895)   
None 187 (20.9) 
Primary 546 (61.0) 
Secondary 133 (14.9) 
University 29 (3.2) 
Socio-economic status (N=891)   
Low level 309 (34.7) 
Middle level  573 (64.3) 
High level 9 (1.0) 
District of origin (N=1002)   
Musanze (North) 206 (20.6) 
Rwamagana (East) 131 (13.1) 




Table 2: gynecological-obstetrical, clinical and behavioral characteristics 
of women screened for cervical cancer 
Characteristic n (%) 
Number of pregnancies (N=960)   
1 71 (7.4) 
2-3 265 (27.6) 
4-5 307 (32.0) 
> 5 317 (33.0) 
Number of children born  (N=957)   
1 73 (7.6) 
2-3 304 31.8) 
4-5 319 (33.3) 
> 5 261 27.3) 
Age of the first pregnancy (N=806)   
< 20 years 276 (34.2) 
20-35 years 527 (65.4) 
> 35 years 3 (0.4) 
Oral contraceptive pills (N=102)   
≤5 years 82 (80.4) 
>5 years 20 (19.6) 
Age of first intercourse (N=851)   
<20 years 406 (47.8) 
≥20 years 445 (52.3) 
Number of sexual partners (N=929)   
1 612 (65.9) 
2-5 292 (31.4) 
>5 25 (2.7) 
Self-Reported HIV Status (N=1002)   
Negative 787 (78.5) 
Positive 98 (9.8) 
Unknown 117 (11.7) 
Suspicion of STI (N=1002)   
No 851 (84.9) 
Yes 151 (15.1) 
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Total 1002 60 5.9 4.5-7.5 17 1.7 
0.9-
2.5 
Age group               
30-35 years 478 41 8.6 6.1-11.1 4 0.8 
0.2-
1.7 
36-40 years 274 8 2.9 0.9- 4.9 3 1.1 
0.1-
2.3 
41-45 years 135 5 3.7 0.5- 6.9 5 3.7 
0.5-
6.9 
45-50 years 114 6 5.3 1.1- 9.4 5 4.4 
0.6-
8.2 
Marital status               
Single 16 0 0 0-0.2+ 0 0 
0-
0.2+ 
Married 747 50 6.7 4.9-8.5 15 2 
1.0-
3.0 
Divorced 66 3 4.5 0.6-10.0 2 3.0 
1.3-
7.5 
Widowed 62 0 0 0-0.1+ 0 0 
0-
0.1+ 
Age of first 
intercourse 
              
<20 years 406 31 7.6 4.8-9.9 7 1.7 
0.4-
3.0 







              
1 612 32 5.2 3.3-6.8 9 1.5 
0.5-
2.4 
2-5 292 18 6.1 3.4-8.9 7 2.4 
0.6-
4.2 
>5 25 4 16.0 0.6-31.4 0 0 
0-
0.1+ 
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 Table 4: risk factors of cervical cancer and cervical pre-cancerous lesions (VIA 
positive) among women screened 















Age group               
30-40 years 7.4 1.00     1.00     






              











              
1-3 children 9.5 1.00     1.00     




Age of the 
first 
pregnancy 
              




≥20 years 6.4 1.00     1.00     
Age of first 
intercourse 
              








            - 
1 partner 6.7 1.00     -     
>1 partner 6.3 1.40 0.85-2.30 182 - -   
  
 
 
 
